#cancer-research

#cancer-research

We think it's a great cause, so really just happy to help. We're currently closed to new investors, so this is not a marketing trip.

Intratumoural heterogeneity complicates effective treatment of medulloblastoma, which is defined by diverse molecular populations, particularly in groups 3 and 4.

"As we look to the future, I am excited to lead us into the next chapter - expanding our reach, deepening our academic mission, and advancing care for the patients and communities we serve."

Yaw Bediako, an immunologist, founded Yemaachi Biotech to address the significant lack of cancer research in Africa, highlighting the continent's hidden cancer burden.

"It's a super exciting clinical tool that we now have available... We are already getting calls and emails from colleagues and from dog owners from all over the world."

Henderson's work aims to identify susceptible patients and develop early screening regimens, significantly influencing policy and practice in childhood cancer care.